Figure 1.
Flow diagram of patients receiving first allo-HCT in Calgary 2003-2011 reviewed for the study. *Did not complete acyclovir/valacyclovir before end of follow-up.

Flow diagram of patients receiving first allo-HCT in Calgary 2003-2011 reviewed for the study. *Did not complete acyclovir/valacyclovir before end of follow-up.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal